Exploring the multifaceted role of direct interaction between cancer cells and fibroblasts in cancer progression
- PMID: 38863965
- PMCID: PMC11165130
- DOI: 10.3389/fmolb.2024.1379971
Exploring the multifaceted role of direct interaction between cancer cells and fibroblasts in cancer progression
Abstract
The interaction between the tumor microenvironment (TME) and the cancer cells is a complex and mutually beneficial system that leads to rapid cancer cells proliferation, metastasis, and resistance to therapy. It is now recognized that cancer cells are not isolated, and tumor progression is governed among others, by many components of the TME. The reciprocal cross-talk between cancer cells and their microenvironment can be indirect through the secretion of extracellular matrix (ECM) proteins and paracrine signaling through exosomes, cytokines, and growth factors, or direct by cell-to-cell contact mediated by cell surface receptors and adhesion molecules. Among TME components, cancer-associated fibroblasts (CAFs) are of unique interest. As one of the most abundant components of the TME, CAFs play key roles in the reorganization of the extracellular matrix, facilitating metastasis and chemotherapy evasion. Both direct and indirect roles have been described for CAFs in modulating tumor progression. In this review, we focus on recent advances in understanding the role of direct contact between cancer cells and cancer-associated fibroblasts (CAFs) in driving tumor development and metastasis. We also summarize recent findings on the role of direct contact between cancer cells and CAFs in chemotherapy resistance.
Keywords: EMT-epithelial to mesenchymal transformation; TME; cancer-associated fibroblasts; chemotherapy resistance; direct cell-cell communication.
Copyright © 2024 Dhungel and Dragoi.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Dynamic interactions in the tumor niche: how the cross-talk between CAFs and the tumor microenvironment impacts resistance to therapy.Front Mol Biosci. 2024 Feb 22;11:1343523. doi: 10.3389/fmolb.2024.1343523. eCollection 2024. Front Mol Biosci. 2024. PMID: 38455762 Free PMC article. Review.
-
Cancer associated-fibroblast-derived exosomes in cancer progression.Mol Cancer. 2021 Dec 1;20(1):154. doi: 10.1186/s12943-021-01463-y. Mol Cancer. 2021. PMID: 34852849 Free PMC article. Review.
-
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.Mol Cancer. 2021 Oct 11;20(1):131. doi: 10.1186/s12943-021-01428-1. Mol Cancer. 2021. PMID: 34635121 Free PMC article. Review.
-
Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.Front Immunol. 2022 Oct 5;13:996145. doi: 10.3389/fimmu.2022.996145. eCollection 2022. Front Immunol. 2022. PMID: 36275750 Free PMC article. Review.
-
Intercellular crosstalk between cancer cells and cancer-associated fibroblasts via exosomes in gastrointestinal tumors.Front Oncol. 2024 Feb 23;14:1374742. doi: 10.3389/fonc.2024.1374742. eCollection 2024. Front Oncol. 2024. PMID: 38463229 Free PMC article. Review.
Cited by
-
PPIC-labeled CAFs: Key players in neoadjuvant chemotherapy resistance for gastric cancer.Transl Oncol. 2024 Oct;48:102080. doi: 10.1016/j.tranon.2024.102080. Epub 2024 Aug 7. Transl Oncol. 2024. PMID: 39116799 Free PMC article.
-
The Role of TGF-β1 and Mutant SMAD4 on Epithelial-Mesenchymal Transition Features in Head and Neck Squamous Cell Carcinoma Cell Lines.Cancers (Basel). 2024 Sep 16;16(18):3172. doi: 10.3390/cancers16183172. Cancers (Basel). 2024. PMID: 39335144 Free PMC article.
References
-
- Alexeyenko A., Alkasalias T., Pavlova T., Szekely L., Kashuba V., Rundqvist H., et al. (2015). Confrontation of fibroblasts with cancer cells in vitro: gene network analysis of transcriptome changes and differential capacity to inhibit tumor growth. J. Exp. Clin. Cancer Res. 34 (1), 62. 10.1186/s13046-015-0178-x - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials